Miller Investment Management’s AbbVie ABBV Stock Holding History

Miller Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$737K	Hold	3,390	–	–	0.07%	58
2025 Q4	$775K	Hold	3,390	–	–	0.08%	61
2025 Q3	$785K	Hold	3,390	–	–	0.08%	70
2025 Q2	$629K	Hold	3,390	–	–	0.07%	76
2025 Q1	$710K	Hold	3,390	–	–	0.08%	73
2024 Q4	$602K	Hold	3,390	–	–	0.07%	79
2024 Q3	$669K	Hold	3,390	–	–	0.07%	76
2024 Q2	$581K	Hold	3,390	–	–	0.07%	78
2024 Q1	$617K	Hold	3,390	–	–	0.08%	79
2023 Q4	$525K	Hold	3,390	–	–	0.07%	80
2023 Q3	$505K	Hold	3,390	–	–	0.08%	73
2023 Q2	$457K	Hold	3,390	–	–	0.07%	79
2023 Q1	$540K	Hold	3,390	–	–	0.09%	71
2022 Q4	$548K	Hold	3,390	–	–	0.09%	71
2022 Q3	$455K	Hold	3,390	–	–	0.1%	68
2022 Q2	$519K	Hold	3,390	–	–	0.11%	62
2022 Q1	$550K	Hold	3,390	–	–	0.09%	67
2021 Q4	$459K	Hold	3,390	–	–	0.07%	74
2021 Q3	$366K	Sell	3,390 -500	-13%	-$57.1K	0.06%	73
2021 Q2	$438K	Hold	3,890	–	–	0.08%	62
2021 Q1	$421K	Hold	3,890	–	–	0.08%	60
2020 Q4	$417K	Hold	3,890	–	–	0.08%	61
2020 Q3	$341K	Hold	3,890	–	–	0.08%	57
2020 Q2	$382K	Hold	3,890	–	–	0.11%	55
2020 Q1	$296K	Hold	3,890	–	–	0.1%	59
2019 Q4	$344K	Hold	3,890	–	–	0.08%	62
2019 Q3	$295K	Hold	3,890	–	–	0.07%	64
2019 Q2	$283K	Hold	3,890	–	–	0.06%	64
2019 Q1	$313K	Hold	3,890	–	–	0.08%	63
2018 Q4	$359K	Hold	3,890	–	–	0.11%	59
2018 Q3	$368K	Hold	3,890	–	–	0.11%	63
2018 Q2	$360K	Hold	3,890	–	–	0.11%	68
2018 Q1	$368K	Sell	3,890 -750	-16%	-$82.4K	0.12%	60
2017 Q4	$449K	Hold	4,640	–	–	0.14%	56
2017 Q3	$412K	Hold	4,640	–	–	0.13%	56
2017 Q2	$336K	Sell	4,640 -100	-2%	-$6.72K	0.12%	61
2017 Q1	$309K	Hold	4,740	–	–	0.11%	62
2016 Q4	$297K	Sell	4,740 -100	-2%	-$6.1K	0.1%	65
2016 Q3	$305K	Hold	4,840	–	–	0.11%	63
2016 Q2	$300K	Buy	4,840 +200	+4%	+$12.2K	0.12%	60
2016 Q1	$265K	Hold	4,640	–	–	0.12%	57
2015 Q4	$275K	Hold	4,640	–	–	0.11%	57
2015 Q3	$252K	Hold	4,640	–	–	0.1%	58
2015 Q2	$312K	Hold	4,640	–	–	0.12%	56
2015 Q1	$272K	Buy	4,640 +500	+12%	+$30.2K	0.1%	62
2014 Q4	$271K	Hold	4,140	–	–	0.1%	57
2014 Q3	$239K	Hold	4,140	–	–	0.11%	59
2014 Q2	$234K	Hold	4,140	–	–	0.1%	64
2014 Q1	$213K	Hold	4,140	–	–	0.12%	72
2013 Q4	$219K	Buy	+4,140	New	+$203K	0.12%	66

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Miller Investment Management's ABBV Position: Q1 2026 in Review

Miller Investment Management held its AbbVie (ABBV) position steady in Q1 2026 at 3,390 shares worth $737K. The position accounts for 0.07% of the portfolio, ranked #58.

Miller Investment Management first reported a position in ABBV in Q4 2013 and has held it in 50 quarters since. The position peaked at $785K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Miller Investment Management held 3,390 shares of AbbVie worth $737K as of Q1 2026.
Miller Investment Management left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.07% of Miller Investment Management's portfolio in Q1 2026, its #58 holding.
Miller Investment Management first reported a position in AbbVie in Q4 2013 and has held it in 50 quarters since.
Miller Investment Management's AbbVie position peaked at $785K in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Miller Investment Management's 13F filing for Q1 2026, filed 8 May 2026.